| The Republic's sovereign wealth fund GIC and Chinese aesthetic and corective company Bloomage BioTechnology on Thursday (Nov 5) announced a joint investment agreement, where GIC will become a key shareholder of Bloomage BioTech by investing HK$659 million (S$119.43 million) into the company.
In a media release, Bloomage BioTech said GIC would subscribe for its shares to support the company in building up the aesthetic medical ecosystem in China "through organic growth and acquisitions". The investment includes the subscription for HK$465 million of convertible bonds and HK$194 million of new shares, of which:..............................................Full Article: Source
|